GAM
TECH icon

Groupama Asset Management’s Bio-Techne TECH Stock Holding History

Groupama Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,600
Closed -$271K – 452
2025
Q4 		$271K Sell
4,600
-476
-9% -$28.9K ﹤0.01% 406
2025
Q3 		$282K Buy
+5,076
New +$272K ﹤0.01% 423
2024
Q4 		– Sell
-3,566
Closed -$229K – 495
2024
Q3 		$229K Buy
3,566
+81
+2% +$6.09K 0.01% 395
2024
Q2 		$250K Sell
3,485
-1,603
-32% -$118K ﹤0.01% 407
2024
Q1 		$756K Sell
5,088
-6,953
-58% -$498K 0.01% 339
2023
Q4 		$929K Buy
+12,041
New +$793K 0.02% 287

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Groupama Asset Management's TECH Position: Q1 2026 in Review

Groupama Asset Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 4,600 shares — an estimated $271K sold.

Groupama Asset Management first reported a position in TECH in Q4 2023 and held it in 6 quarters. The position peaked at $929K in Q4 2023. 585 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Groupama Asset Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Groupama Asset Management sold 4,600 Bio-Techne shares in Q1 2026, an estimated $271K.
  • Groupama Asset Management first reported a position in Bio-Techne in Q4 2023 and held it in 6 quarters.
  • Groupama Asset Management's Bio-Techne position peaked at $929K in Q4 2023.
  • 585 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Groupama Asset Management's 13F filing for Q1 2026, filed 22 May 2026.